Mitogenic activity of endothelin on human cultured prostatic smooth muscle cells

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 123-128

  Saita, Yuji ^a   Yazawa, Hidenori ^a   Koizumi, Tomonobu ^a   Morita, Takashi ^b   Tamura, Toshinari ^a   Takenaka, Toichi ^a   Honda, Kazuo ^a  

^a Inst for Drug Discovery Research   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Endothelin receptor; Proliferation; Prostate; Smooth muscle cell

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; HYPERPLASIA; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SWINE;

AGED; CELLS, CULTURED; DNA; ENDOTHELIN-1; ENDOTHELIN-3; ENDOTHELINS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MITOSIS; MUSCLE, SMOOTH; PERTUSSIS TOXIN; PROSTATE; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; VIRULENCE FACTORS, BORDETELLA;

EID: 0032524282     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00183-6     Document Type: Article

References (32)

1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
2. Barry M.J. Medical outcomes research and benign prostatic hyperplasia. Prostate. 3(Suppl.):1990;61-74.
3. Battistini B., Chailler P., D'Orléans-Juste P., Brière N., Sirois P. Growth regulatory properties of endothelins. Peptides. 14:1993;385-399.
4. Bobik A., Grooms A., Millar J.A., Mitchell A., Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 258:1990;C408-C415.
5. Caine M., Pfau A., Perlberg S. The use of alpha adrenergic blockers in benign prostatic obstruction. Br. J. Urol. 48:1976;255-263.
6. Chambard J.C., Paris S., L'Allemain G., Pouyssegur J. Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin. Nature. 326:1987;800-803.
7. A antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS Lett. 302:1992;243-246.
8. Gilman G.G. G proteins: transducers of receptor-generated signals. Ann. Rev. Biochem. 56:1987;615-649.
9. Hassoun P.M., Thappa V., Landman M.J., Fanburg B.L. Mitogenic activity on pulmonary artery smooth muscle cell and release from hypoxic endothelial cells. Proc. Soc. Exp. Biol. Med. 199:1992;165-170.
10. Imokawa G., Tada Y., Kimura M. Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem. J. 314:1996;305-312.
11. Kassen A., Sutkowski D.M., Ahn H., Sensibar J.A., Kozlowski J.M., Lee C. Stromal cells of the human prostate: initial isolation and characterization. Prostate. 28:1996;89-97.
12. Kawabe K., Ueno A., Takimoto Y., Aso Y., Kato H. Use of an α1 blocker, YM617, in the treatment of benign prostatic hypertrophy. J. Urol. 144:1990;908-912.
13. Kobayashi S., Tang R., Wang B., Opgenorth T., Langenstorer P., Shapiro E., Lepor H. Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol. Pharmacol. 45:1994;306-311.
14. Kobayashi S., Tang R., Wang B., Opgenorth T., Stein E., Shapiro E., Lepor H. Localization of endothelin receptors in the human prostate. J. Urol. 151:1994;763-766.
15. Kondo S., Morita T., Tashima Y. Benign prostatic hypertrophy affects the endothelin receptor density in the human urinary bladder and prostate. Urol. Int. 54:1995;198-203.
16. Langenstroer P., Tang R., Shapiro E., Divish B., Opgenorth T., Lepor H. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J. Urol. 149:1993;495-499.
17. Masaki T. Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrinol. Rev. 14:1993;256-268.
18. Masaki T., Yanagisawa M., Goto K. Physiology and pharmacology of endothelins. Med. Res. Rev. 12:1992;391-421.
19. A receptor-mediated phenomenon. Br. J. Pharmacol. 118:1996;191-197.
20. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
21. Saita Y., Koizumi T., Yazawa H., Morita T., Takenaka T., Honda K. Endothelin receptors and their cellular signal transduction mechanism in human cultured prostatic smooth muscle cells. Br. J. Pharmacol. 121:1997;687-694.
22. Sakurai T., Yanagisawa M., Takuwa Y., Miyazzaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
23. Shapiro E., Hartanto V., Becich M.J., Lepor H. The relative proportion of stromal and epithelial hyperplasia is regulated to the development of symptomatic BPH. J. Urol. 147:1992;1293-1297.
24. Shapiro E., Hartanto V., Lepor H. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J. Urol. 147:1992;1167-1170.
25. Sherwood E.R., Fong C.-J., Lee C., Kozlowski J.M. Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology. 130:1992;2955-2963.
26. Simonson M.S. Endothelins: multifunctional renal peptides. Physiol. Rev. 73:1993;375-411.
27. 2+ channels mediate protein tyrosine kinase activation by endothelin-1. Am. J. Physiol. 270:1996;F790-F797.
28. A receptors. Eur. J. Pharmacol. 245:1993;229-232.
29. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
30. 3H] (o-ethoxyphenoxy)ethyl[amino]-propyl]-2-methoxybenzenesulfonamide HCI, a potent and selective alpha-1 adrenoceptor radioligand J. Pharmacol. Exp. Ther. 263:1992;201-206.
31. Yazawa H., Saita Y., Iida E., Honma Y., Morita T., Honda K. Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J. Urol. 152:1994;2173-2177.
32. Zamora M.A., Dempsey E.C., Walchak S.J., Stelzner T.J. BQ123, an ETA receptor antagonist, inhibits endothelin-1-induced proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 9:1993;429-433.